clinical trials

Eisai-Biogen Alzheimer's Drug Shows Amyloid Reduction, Disease-Modifying Effect
BioSpace
Thu, 11/11/21 - 10:55 am
Eisai
Biogen
lecanemab
Alzheimer's disease
clinical trials
Immatics' cell therapy blasts solid tumors in phase 1, but durability spooks investors. Will dialing up the dose help?
Fierce Biotech
Wed, 11/10/21 - 10:45 am
Immatics
cell therapy
solid tumors
clinical trials
Largest psilocybin trial finds the psychedelic is effective in treating serious depression
Stat
Tue, 11/9/21 - 11:37 pm
psychedelic drugs
psilocybin
treatment-resistant depression
COMPASS Pathways
clinical trials
Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability
Fierce Biotech
Tue, 11/9/21 - 10:49 am
Mirati Therapeutics
Amgen
KRAS
clinical trials
Merck
Keytruda
Regeneron COVID-19 antibody drug reduces infection risk 82% in clinical trial
Beckers Hospital Review
Mon, 11/8/21 - 11:03 am
Regeneron
COVID-19
antibodies
clinical trials
Propel fails to propel Nektar
EP Vantage
Mon, 11/8/21 - 10:48 am
Nektar Therapeutics
Merck
bempegaldesleukin
clinical trials
metastatic non-small cell lung cancer
Trial flop busts Deciphera’s blockbuster hopes for Qinlock
Pharmaforum
Sun, 11/7/21 - 10:57 pm
Deciphera Pharma
Qinlock
clinical trials
GIST
These Clinical Results Are Good News for AstraZeneca
Motley Fool
Sun, 11/7/21 - 10:52 pm
AstraZeneca
Imfinizi
biliary tract cancer
clinical trials
Moderna scraps lead mRNA chikungunya candidate after phase 1, slowing push beyond prophylactic vaccines
Fierce Biotech
Fri, 11/5/21 - 09:44 am
Moderna Therapeutics
vaccines
MRNA
chikungunya virus
clinical trials
Sangamo's Fabry gene therapy clears early clinical test, firing starting gun on preparations for phase 3
Fierce Biotech
Thu, 11/4/21 - 10:48 am
Sangamo Therapeutics
Fabry disease
gene therapy
clinical trials
ST-920
ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again
Fierce Biotech
Thu, 11/4/21 - 10:27 am
BeiGene
Brukinsa
leukemia
clinical trials
AbbVie
JNJ
Imbruvica
Why did FDA ask Amgen to add low-dose trial of Lumakras?
Korea Biomed
Wed, 11/3/21 - 10:47 am
FDA
Amgen
clinical trials
Lumakras
oncology
cancer
Sage changes primary endpoint in key study months after analysts fret about depression drug's durability
Endpoints
Wed, 11/3/21 - 10:41 am
SAGE Therapeutics
clinical trials
zuranolone
depression
endpoints
SSRIs
Teva's Risperidone Injectable Wards Off Schizophrenia Relapse in Phase III
BioSpace
Tue, 11/2/21 - 10:55 am
Teva Pharmaceutical
schizophrenia
clinical trials
Risperidone
TV-46000
Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster?
Motley Fool
Tue, 11/2/21 - 10:44 am
Vertex Pharmaceuticals
cystic fibrosis
clinical trials
VX-880
type 1 diabetes
Idorsia sets itself up for failure
EP Vantage
Mon, 11/1/21 - 10:57 pm
Idorsia
cenerimod
lupus
clinical trials
AbbVie preps filings after ABBV-951 tops oral Parkinson’s drugs in trial
Pharmaforum
Sat, 10/30/21 - 10:48 pm
AbbVie
ABV-951
Parkinson's Disease
clinical trials
AbbVie Says Cariprazine Met Primary Endpoint In Phase 3 Study For Major Depressive Disorder
NASDAQ
Sat, 10/30/21 - 10:43 pm
AbbVie
clinical trials
cariprazine
major depressive disorder
Rafael Pharmaceuticals’ Cancer Metabolism Drug Fails Phase III Assessment
BioSpace
Fri, 10/29/21 - 10:59 am
Rafeal Pharmaceuticals
clinical trials
CPI-613
devimistat
cancer
Positive Results in Hand, AbbVie Eyes Potential Approval for Parkinson’s Treatment
BioSpace
Thu, 10/28/21 - 10:16 pm
AbbVie
Parkinson's Disease
ABBV-951
clinical trials

Pages